Sigachi Industries Limited (SIGACHI.BO)
INR 37.71
(4.63%)
INR 37.71
(4.63%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.47 Billion INR | 24.46% |
| 2022 | 529.11 Million INR | 4.17% |
| 2021 | 507.95 Million INR | 37.61% |
| 2020 | 369.13 Million INR | 60.01% |
| 2019 | 230.69 Million INR | -5.87% |
| 2018 | 245.06 Million INR | 97.14% |
| 2017 | 124.31 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 178.77 Million INR | 39.25% |
| 2023 Q3 | 197.68 Million INR | 4.63% |
| 2023 Q2 | 188.94 Million INR | 31.66% |
| 2023 Q4 | 128.37 Million INR | -35.06% |
| 2023 Q1 | 143.51 Million INR | 40.73% |
| 2023 FY | 658.51 Million INR | 24.46% |
| 2022 Q4 | 101.97 Million INR | -16.65% |
| 2022 Q3 | 122.35 Million INR | -13.88% |
| 2022 Q2 | 142.08 Million INR | -8.09% |
| 2022 Q1 | 154.58 Million INR | 11.58% |
| 2022 FY | 529.11 Million INR | 4.17% |
| 2021 Q2 | 127.51 Million INR | 9.65% |
| 2021 FY | 507.95 Million INR | 37.61% |
| 2021 Q4 | 138.53 Million INR | 16.25% |
| 2021 Q3 | 119.17 Million INR | -6.54% |
| 2021 Q1 | 116.28 Million INR | 5.58% |
| 2020 FY | 369.13 Million INR | 60.01% |
| 2020 Q3 | 87.25 Million INR | -4.18% |
| 2020 Q2 | 91.06 Million INR | -2.71% |
| 2020 Q1 | 93.59 Million INR | 0.0% |
| 2020 Q4 | 110.13 Million INR | 26.22% |
| 2019 FY | 230.69 Million INR | -5.87% |
| 2018 FY | 245.06 Million INR | 97.14% |
| 2017 FY | 124.31 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 74.403% |
| Aurobindo Pharma Limited | 42.2 Billion INR | 96.508% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 83.585% |
| Granules India Limited | 6.81 Billion INR | 78.378% |
| Indoco Remedies Limited | 1.29 Billion INR | -14.03% |
| Achyut Healthcare Limited | 4.43 Million INR | -33110.816% |
| Ajanta Pharma Limited | 19.67 Billion INR | 92.51% |
| Alkem Laboratories Limited | 19.46 Billion INR | 92.427% |
| Alpa Laboratories Limited | 184.49 Million INR | -698.873% |
| Brooks Laboratories Limited | 14.44 Million INR | -10107.036% |
| AstraZeneca Pharma India Limited | 1.71 Billion INR | 14.184% |
| Bajaj HealthCare Limited | - INR | -Infinity% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | -19.732% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 97.824% |
| Eris Lifesciences Limited | 5.18 Billion INR | 71.556% |
| FDC Limited | 2.98 Billion INR | 50.643% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 77.333% |
| Gufic Biosciences Limited | 1.32 Billion INR | -10.827% |
| Ind-Swift Laboratories Limited | 4.42 Billion INR | 66.658% |
| Ipca Laboratories Limited | 7.98 Billion INR | 81.532% |
| Jagsonpal Pharmaceuticals Limited | 508.13 Million INR | -190.063% |
| Krebs Biochemicals & Industries Limited | -151.95 Million INR | 1069.943% |
| Lasa Supergenerics Limited | -458 Million INR | 421.808% |
| Laurus Labs Limited | 3.94 Billion INR | 62.673% |
| Lupin Limited | 28.04 Billion INR | 94.744% |
| Mankind Pharma Limited | 21.51 Billion INR | 93.15% |
| Medicamen Biotech Limited | - INR | -Infinity% |
| Medico Remedies Limited | 100.3 Million INR | -1369.488% |
| Megasoft Limited | -121.1 Million INR | 1317.05% |
| NATCO Pharma Limited | 25.96 Billion INR | 94.323% |
| Piramal Pharma Limited | 4.55 Billion INR | 67.656% |
| RPG Life Sciences Limited | 2.29 Billion INR | 35.702% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 98.587% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 68.012% |
| Syncom Formulations (India) Limited | 249.25 Million INR | -491.33% |
| Unichem Laboratories Limited | - INR | -Infinity% |
| Wanbury Limited | 569.71 Million INR | -158.707% |
| Windlas Biotech Limited | 1.29 Billion INR | -13.474% |
| ZIM Laboratories Limited | 253.82 Million INR | -480.665% |
| Zydus Lifesciences Limited | 43.1 Billion INR | 96.581% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 135.817% |
| Divi's Laboratories Limited | 33.08 Billion INR | 95.544% |
| Hester Biosciences Limited | 364.81 Million INR | -304.017% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 47.096% |
| Amrutanjan Health Care Limited | 457.54 Million INR | -222.132% |
| Bal Pharma Limited | 233.9 Million INR | -530.115% |
| Strides Pharma Science Limited | 5.22 Billion INR | 71.796% |
| Venus Remedies Limited | 534.65 Million INR | -175.674% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 52.882% |
| Nectar Lifesciences Limited | 923.8 Million INR | -59.546% |
| Shilpa Medicare Limited | 1.36 Billion INR | -7.877% |
| Aarti Drugs Limited | 7.14 Billion INR | 79.382% |
| IOL Chemicals and Pharmaceuticals Limited | 1.59 Billion INR | 7.697% |
| Suven Life Sciences Limited | -1.22 Billion INR | 220.237% |
| Ind-Swift Limited | 1.22 Billion INR | -20.223% |
| Valiant Laboratories Limited | - INR | -Infinity% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.28 Billion INR | 89.681% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 138.254% |
| Themis Medicare Limited | 392.58 Million INR | -275.43% |
| Hikal Limited | 32.11 Million INR | -4490.146% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 94.182% |
| Sequent Scientific Limited | - INR | -Infinity% |
| Novartis India Limited | 626.5 Million INR | -135.259% |
| Wockhardt Limited | -670 Million INR | 319.984% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 71.596% |
| Biofil Chemicals and Pharmaceuticals Limited | 9.06 Million INR | -16152.561% |
| Neuland Laboratories Limited | 5.31 Billion INR | 72.285% |
| Morepen Laboratories Limited | 4.17 Billion INR | 64.687% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | -608.434% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | -5267.82% |